Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

A Sub-Study With Patients in APO401 to Evaluate Adverse Events During Dose Introduction in Apomorphine-naïve Patients.

This study has been completed.
Information provided by:
Mylan Bertek Pharmaceuticals Identifier:
First received: September 2, 2005
Last updated: NA
Last verified: November 2002
History: No changes posted
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Estimated Study Completion Date: August 2002
  Estimated Primary Completion Date: No date given